Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-15 ASELAGE STEVE Director Sale −1,838 $17.82 $33K 255,966
2019-05-14 ROTE WILLIAM E. Senior Vice President, R&D Sale −813 $17.78 $14K 18,997
2019-05-14 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −525 $17.75 $9K 20,033
2019-05-14 ASELAGE STEVE Director Sale −1,838 $17.79 $33K 257,804
2019-05-13 Poole Sandra Director Grant or award +3,500 3,500
2019-05-13 Poole Sandra Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2019-05-09 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +6,000 20,558
2019-05-09 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Employee stock option (right to buy) +40,000 40,000
2019-05-09 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Performance-based restricted stock units +6,000 6,000
2019-05-09 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +6,000 19,810
2019-05-09 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Employee stock option (right to buy) +40,000 40,000
2019-05-09 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Performance-based restricted stock units +6,000 6,000
2019-05-09 Rosenberg Noah L. Chief Medical Officer Grant or award +6,000 16,000
2019-05-09 Rosenberg Noah L. Chief Medical Officer Grant or award · Employee stock option (right to buy) +40,000 40,000
2019-05-09 Rosenberg Noah L. Chief Medical Officer Grant or award · Performance-based restricted stock units +6,000 6,000
2019-05-09 Clague Laura Chief Financial Officer Grant or award +6,000 16,000
2019-05-09 Clague Laura Chief Financial Officer Grant or award · Employee stock option (right to buy) +40,000 40,000
2019-05-09 Clague Laura Chief Financial Officer Grant or award · Performance-based restricted stock units +6,000 6,000
2019-05-09 Dube Eric M Chief Executive Officer Grant or award · Performance-based restricted stock units +6,000 6,000
2019-05-08 Squarer Ron Director Grant or award +2,000 8,875

Page 46 of 51 · 1,020 trades